Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Myeloproliferative Disorders
×
anagrelide
×
Clear all
Filters
3
NCT04285086
2025-08-13
SURPASS ET
PharmaEssentia
Phase 3
Active not recruiting
174 enrolled
NCT02076815
2015-07-29
TEAM-ET
AOP Orphan Pharmaceuticals AG
Phase 3
Completed
106 enrolled